ARCHIVES

FDA Issues Final Rules On Patient Access To Investigational Drugs

This article is from The Cancer Letter archive.

Vol. 35 No. 33 | September 11, 2009

Download PDF Visit The Full Archive

Related Articles

Chabner On Taxol, NSABP: “Makes You Lose Confidence In The Political Process”

May 12, 1995

Groups Point to NCI Restrictions As Source Of Problems, Discuss Prioritizing Trials

July 11, 2003

ICCCR Issues RFP For Cancer Risk Scale

March 6, 1992

Bailer NEJM “Irresponsible, Purposely Misleading,” Ignored Facts, DeVita Tells NCA

May 23, 1986

Breast Cancer Funding: Shalala Approves Agreement Over Disputed $14 Million

August 8, 1997

Proposed Guidelines For Clinical Tests Of Oncologic Drugs

November 28, 1975